beta

PTLA

Portola Pharmaceuticals, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.

Market Cap: 1.42 Billion

Primary Exchange: NASDAQ

Website: http://www.portola.com

Shares Outstanding: 78.5 Million

Float: 77.4 Million

Dividend: (%)

Beta: 1.1722802646663404

Sector: Health Technology

Industry: Pharmaceuticals: Other

Ethical Flags

Longest drawdown: 1211 trading days

From: 2017-07-21 To: 2020-07-02

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud